We are live on
!
Find out more
BDF
Balasa Dinverno & Foltz Portfolio holdings
AUM
$1.58B
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+4.69%
1 Year Est. Return
-17.55%
3 Year Est. Return
+23.2%
5 Year Est. Return
+47.16%
10 Year Est. Return
–
AUM
$1.25B
AUM Growth
+$41.9M
(+3.5%)
Cap. Flow
-$10.5M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
63.99%
Holding
314
New
23
Increased
136
Reduced
120
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$2.98M |
| 2 |
iShares International Equity Factor ETF
INTF
|
+$2.59M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$2.48M |
| 4 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$2.36M |
| 5 |
Microsoft
MSFT
|
+$1.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Small-Cap Growth ETF
VBK
|
+$9.2M |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$5.65M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$5.46M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$2.49M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$1.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.74% |
| 2 | Financials | 4% |
| 3 | Healthcare | 3.52% |
| 4 | Consumer Staples | 2.49% |
| 5 | Consumer Discretionary | 2.38% |
Similar funds
RHBC
ACM
SCA
WFA
CA
RIG
IC
CCP
Balasa Dinverno & Foltz's Q1 2021 Portfolio in Review
As of Q1 2021, Balasa Dinverno & Foltz held 314 positions worth $1.25B, up 3.5% from $1.21B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Balasa Dinverno & Foltz's Q1 2021 filing shows 23 new, 136 increased, 120 reduced and 9 closed positions. Its largest new stake was Alexion Pharmaceuticals: 1,959 shares worth $300K. The largest sale was Vanguard Morningstar Small-Cap Growth ETF, an estimated $9.2M.
By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 6.6% a quarter earlier, followed by Financials and Healthcare.
- Balasa Dinverno & Foltz's largest Q1 2021 buy was Alexion Pharmaceuticals: 1,959 shares worth $300K.
- Balasa Dinverno & Foltz added most to Vanguard Morningstar Growth ETF in Q1 2021, an estimated $2.98M increase.
- Balasa Dinverno & Foltz's biggest Q1 2021 reduction was Vanguard Morningstar Small-Cap Growth ETF, cutting an estimated $9.2M.
- Balasa Dinverno & Foltz fully exited American Water Works in Q1 2021, selling an estimated $332K.
- Balasa Dinverno & Foltz's ten largest holdings make up 64% of its $1.25B portfolio in Q1 2021.
- Balasa Dinverno & Foltz opened 23 new positions and closed 9 in Q1 2021.
- Balasa Dinverno & Foltz's portfolio value rose 3.5% quarter-over-quarter to $1.25B.
Based on Balasa Dinverno & Foltz's 13F filing for Q1 2021, filed 29 Apr 2021.